Glanbia PLC (GL9) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage.
Total Revenue Chart for Glanbia PLC
Glanbia PLC (GL9) revenue for FY2025 was EUR 3.9B, a 2.8% change from FY2024. Glanbia PLC's revenue grew from EUR 232.2M in 1985 to EUR 3.9B in 2025 (1599.6% over 40 years). Earnings per share grew from EUR 0.62 in 2015 to EUR 0.88 in 2022 (41.7%). Revenue compound annual growth rate: 5-year CAGR of 0.6%, 10-year CAGR of 3.6%, 20-year CAGR of 3.9%.
Total Revenue (Euros)
R&D as % of Revenue
Key Stats
- Market Cap
- €5.38B
- Implied Share Price
- €22.24
- Enterprise Value
- €6.14B
- Revenue (TTM)
- €4.10B
- EBITDA
- €486.40M
- Profit Margin
- 5.80%
- Trailing P/E
- 26.48
- Forward P/E
- 15.34
- Price/Book (MRQ)
- 3.31
- Price/Sales (TTM)
- 1.31
- EV/EBITDA
- 15.89
- EV/Revenue
- 1.74
- Dividend Yield
- 2.41%
- Book Value
- €6.73
- Free Cash Flow (FY2025)
- €283.70M
- Free Cash Flow Yield
- 5.28%
Snapshot as of 4th September 2026 — not point-in-time controlled, may lag the live market by a few days.